Press Release Details
Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020
The event will include an overview of Twist Biopharma and its unique approach to antibody discovery facilitated by its precisely synthetized “Library of Libraries” and antibody optimization solution. Twist Biopharma enables its partners to apply next generation drug development to some of the world’s most intractable health challenges.
The program will also feature a series of presentations by three Twist Biopharma customers:
-
Takeda Pharmaceutical Company
Robert Mabry , Ph.D., Head ofGlobal Biologics Research
-
Invetx
Jürgen Horn, Ph.D., Founder and Chief Executive Officer
-
Neogene Therapeutics
Carsten Linnemann , Ph.D., President and Chief Executive Officer
The presentations will be followed by a Q&A session.
The call and accompanying slides will be webcast live on the company's website at https://investors.twistbioscience.com/events-and-presentations/events. To listen to the conference call live, please dial (888) 317-6003 (domestic) or (412) 317-6061 (international) and reference conference ID number 3930359.
A replay of the conference call will be accessible approximately one hour after its completion through
About Twist Biopharma
By leveraging its unique ability to manufacture DNA at scale, Twist Biopharma can construct proprietary antibody libraries precisely designed to match sequences that occur in the human body. This
About
Follow us on Twitter | Facebook | LinkedIn | YouTube
CONTACTS
View source version on businesswire.com: https://www.businesswire.com/news/home/20201013005385/en/
Investor Contact:
212-600-1902
maeve@argotpartners.com
Media Contact:
925- 202-6211
media@twistbioscience.com
Source: